Description
Carbimazole Tablets (5 mg / 10 mg / 20 mg)
Healthy Inc is a specialized global supplier and exporter of advanced endocrinology, metabolic, and hormonal regulatory therapeutics. We provide ultra-high-purity, kinetically precise Carbimazole Uncoated / Film-Coated Tablets (5 mg / 10 mg / 20 mg), manufactured in WHO–GMP certified, highly segregated endocrine oral solid dosage facilities. This “Thionamide Thyroid Peroxidase Inhibitor” is a massive-volume, highly lucrative export to endocrinology clinics, specialized metabolic centers, hospital pharmacies, and government health ministries in LATAM, the CIS, Africa, and Southeast Asia, serving as the globally mandated intervention for the medical management of Hyperthyroidism, thyrotoxicosis, and pre-surgical thyroidectomy preparation.
Product Overview
This highly advanced formulation contains Carbimazole, a highly efficient prodrug that safely travels to the thyroid gland to chemically paralyze the overproduction of toxic thyroid hormones, rescuing the patient from a dangerous hypermetabolic state.
The “Thyroid Peroxidase Blockade & Prodrug” Specialist:
- Mechanism 1 (The TPO Paralyzer): In Graves’ disease, the immune system mistakenly commands the thyroid gland to produce massive, toxic amounts of Thyroxine (T4) and Triiodothyronine (T3), causing the heart to race dangerously and the body to consume its own muscle. Once swallowed, Carbimazole is rapidly converted in the body to its active form, Methimazole. This active agent aggressively binds to and inhibits Thyroid Peroxidase (TPO), the exact enzyme the thyroid uses to attach iodine to proteins. Without this iodination, the assembly line stops, and the production of new thyroid hormones is completely halted.
- Mechanism 2 (The Prodrug Tolerability Advantage): Taking raw Methimazole can cause severe gastrointestinal distress and has a notoriously bitter, foul taste that limits compliance. Carbimazole acts as a highly stable, better-tolerated prodrug, ensuring patients can comfortably maintain the strict, long-term (12-18 month) daily regimen required to achieve permanent disease remission.
- The Thyrotoxic Crisis & Surgical Bridge: Beyond long-term remission, Carbimazole is heavily stockpiled by emergency rooms and surgical wards. It is the mandatory therapy used to rapidly stabilize a patient suffering from a fatal “Thyroid Storm,” and is the required pre-operative bridge to safely lower hormone levels before a surgeon can physically remove the thyroid gland (thyroidectomy).
Product Composition & Strength
We supply this product as a Precision-Blended Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the highly reactive thionamide molecule.
| Active Ingredient | Strength | Primary Clinical Function |
|---|---|---|
| Carbimazole Ph.Eur./BP | 5 mg | Maintenance / Titration Standard: Base therapeutic unit for the gradual tapering of therapy and long-term maintenance of euthyroidism. |
| Carbimazole Ph.Eur./BP | 10 mg / 20 mg | Acute Initiation Standard: High-dose induction therapy to aggressively shut down severe, life-threatening thyrotoxicosis. |
| Excipients | Lactose Monohydrate / Maize Starch / Magnesium Stearate / Povidone K30 / Iron Oxide Yellow (for distinct clinical identification) | Diluent / Binder / Lubricant (Engineered specifically for rapid, complete gastric dissolution to achieve peak methimazole blood levels within 1 to 2 hours) |
*Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict chronic endocrinology dispensing, as patients initiate on high doses and taper down over many months).
Technical & Logistics Specifications
Critical data for Pharmaceutical Importers, Endocrinology Distributors, and Hospital Procurement Boards.
| HS Code | 3004.90.99 (Medicaments containing other active substances – Endocrinology/Antithyroid agents) |
| CAS Number | 22232-54-8 (Carbimazole) |
| Dosage Form | Tablet (Immediate Release Prodrug) |
| Packaging | High-Density Alu-PVC or Alu-Alu Blisters. Protects the formulation from environmental humidity and prevents chemical degradation across Zone IVb tropical climates. |
| Storage | Store strictly below 25°C in a dry place. Protect heavily from Moisture and Light. |
Manufacturing Authority
Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.
- Endocrine Segregation & Low-Dose Blending Engineering: Manufacturing potent antithyroid agents requires elite facility design. The API dust is a severe endocrine disruptor that can cause occupational bone marrow suppression in factory workers if inhaled. Our facilities utilize strictly segregated, negative-pressure containment suites with multi-stage HEPA filtration. Furthermore, we employ advanced geometric dilution to guarantee that the tiny 5 mg API load is perfectly distributed throughout every tablet, absolutely preventing toxic over-suppression (iatrogenic hypothyroidism) in vulnerable patients.
Therapeutic Indications (Human Use)
Indicated for the targeted, multi-pathway management of severe hypermetabolic dysfunction:
- Hyperthyroidism & Graves’ Disease: Medical management of hyperthyroidism to achieve long-term clinical remission.
- Pre-Operative Preparation: Preparation of the hyperthyroid patient for thyroidectomy (to prevent fatal surgical thyroid storm).
- Radioiodine Adjunct: Used before and after radioactive iodine therapy to accelerate the return to normal thyroid function (euthyroid state).
Dosage & Administration
Recommended Dosage (Strictly as per Endocrinologist Guidelines):
- Initial Adult Dosing: Typically ranges from 15 mg to 40 mg daily, given in divided doses until the patient becomes euthyroid (usually 4 to 8 weeks).
- Maintenance Dosing: Once normal thyroid levels are achieved, the dose is drastically reduced to a maintenance level of 5 mg to 15 mg daily. Therapy is typically continued for 12 to 18 months.
- Administration: Can be taken with or without food, but should be taken consistently to maintain stable blood levels. Tablets must be swallowed whole with water.
Safety Warnings (CRITICAL Regulatory & Clinical Data):
- BLACK BOX WARNING / CRITICAL ALERT (Agranulocytosis & Bone Marrow Suppression): Carbimazole can cause a sudden, massive, and potentially fatal drop in white blood cells (neutropenia/agranulocytosis), leaving the patient completely defenseless against infections. Patients MUST be explicitly instructed to stop the drug and seek immediate emergency medical care if they develop a sudden sore throat, mouth ulcers, bruising, or high fever.
- Teratogenicity (Methimazole Embryopathy): Carbimazole crosses the placenta. If used during the first trimester of pregnancy, it carries a severe risk of causing congenital malformations (like aplasia cutis congenita and choanal atresia). Propylthiouracil (PTU) is strictly preferred in the first trimester.
- Severe Hepatotoxicity: Rare but fatal cases of acute liver injury, hepatitis, and jaundice have been reported. Liver function tests must be monitored.
- Cross-Sensitivity: Patients who have developed severe allergic reactions or agranulocytosis to Propylthiouracil (PTU) or Methimazole are highly likely to react to Carbimazole and must not be prescribed this medication.
Global Export & Contract Manufacturing Services
Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving international Pharma Traders, Wholesalers, and Endocrinology Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Hormonal and Metabolic Formulations. Whether you are looking for a reliable Government Tender Supplier for endocrine clinics in the CIS or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely, secure delivery of highly stable, WHO-GMP certified products.








Reviews
There are no reviews yet.